Henry H. Armstrong Associates’s CareDx CDNA Stock Holding History

Henry H. Armstrong Associates’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$457K	Hold	16,036	–	–	0.04%	47
2026 Q1	$278K	Hold	16,036	–	–	0.03%	52
2025 Q4	$302K	Hold	16,036	–	–	0.03%	52
2025 Q3	$233K	Hold	16,036	–	–	0.02%	57
2025 Q2	$313K	Hold	16,036	–	–	0.03%	50
2025 Q1	$285K	Hold	16,036	–	–	0.03%	53
2024 Q4	$343K	Hold	16,036	–	–	0.03%	49
2024 Q3	$501K	Hold	16,036	–	–	0.05%	48
2024 Q2	$249K	Hold	16,036	–	–	0.02%	58
2024 Q1	$170K	Hold	16,036	–	–	0.02%	55
2023 Q4	$192K	Hold	16,036	–	–	0.02%	57
2023 Q3	$112K	Hold	16,036	–	–	0.01%	56
2023 Q2	$136K	Hold	16,036	–	–	0.02%	56
2023 Q1	$147K	Hold	16,036	–	–	0.02%	58
2022 Q4	$183K	Hold	16,036	–	–	0.02%	61
2022 Q3	$273K	Hold	16,036	–	–	0.04%	52
2022 Q2	$344K	Hold	16,036	–	–	0.04%	50
2022 Q1	$593K	Hold	16,036	–	–	0.06%	46
2021 Q4	$729K	Hold	16,036	–	–	0.08%	45
2021 Q3	$1.02M	Hold	16,036	–	–	0.12%	41
2021 Q2	$1.47M	Hold	16,036	–	–	0.17%	37
2021 Q1	$1.09M	Hold	16,036	–	–	0.13%	39
2020 Q4	$1.16M	Hold	16,036	–	–	0.15%	39
2020 Q3	$608K	Hold	16,036	–	–	0.08%	43
2020 Q2	$568K	Buy	+16,036	New	+$456K	0.09%	42
2020 Q1	–	Sell	-16,036	Closed	-$346K	–	59
2019 Q4	$346K	Hold	16,036	–	–	0.05%	55
2019 Q3	$363K	Hold	16,036	–	–	0.06%	40
2019 Q2	$577K	Hold	16,036	–	–	0.08%	35
2019 Q1	$505K	Buy	+16,036	New	+$467K	0.08%	41
2017 Q2	–	Sell	-16,036	Closed	-$22.4M	–	53
2017 Q1	$22.4M	Buy	+16,036	New	+$35.7K	4.25%	8

Other funds holding CDNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Henry H. Armstrong Associates's CDNA Position: Q2 2026 in Review

Henry H. Armstrong Associates held its CareDx (CDNA) position steady in Q2 2026 at 16,036 shares worth $457K. The position accounts for 0.04% of the portfolio, ranked #47.

Henry H. Armstrong Associates first reported a position in CDNA in Q1 2017 and has held it in 30 quarters since. The position peaked at $22.4M in Q1 2017. 228 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

Henry H. Armstrong Associates held 16,036 shares of CareDx worth $457K as of Q2 2026.
Henry H. Armstrong Associates left its CareDx share count unchanged in Q2 2026.
CareDx made up 0.04% of Henry H. Armstrong Associates's portfolio in Q2 2026, its #47 holding.
Henry H. Armstrong Associates first reported a position in CareDx in Q1 2017 and has held it in 30 quarters since.
Henry H. Armstrong Associates's CareDx position peaked at $22.4M in Q1 2017.
228 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Henry H. Armstrong Associates's 13F filing for Q2 2026, filed 7 Jul 2026.